Anteris Technologies Global (AVR) Set to Announce Quarterly Earnings on Wednesday

Anteris Technologies Global (NASDAQ:AVR) is projected to release its Q3 2026 resultson Wednesday, November 11th. Analysts expect Anteris Technologies Global to post earnings of ($0.3114) per share and revenue of $2.75 million for the quarter. Parties are encouraged to explore the company’s upcoming Q3 2026 earnings report for the latest details on the call scheduled for Tuesday, November 17, 2026 at 4:00 PM ET.

Anteris Technologies Global (NASDAQ:AVR) last posted its quarterly earnings data on Tuesday, August 11th. The company reported ($0.30) EPS for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.09). Anteris Technologies Global had a negative net margin of 4,619.27% and a negative return on equity of 77.69%. The company had revenue of $1.01 million for the quarter, compared to the consensus estimate of $1.50 million. During the same quarter last year, the company earned ($0.58) earnings per share. On average, analysts expect Anteris Technologies Global to post ($1.21) EPS for the current fiscal year and ($0.96) EPS for the next fiscal year.

Anteris Technologies Global Stock Performance

NASDAQ:AVR opened at $5.91 on Wednesday. The stock has a market cap of $576.28 million, a price-to-earnings ratio of -3.05 and a beta of 2.02. The business has a fifty day moving average of $7.43 and a 200-day moving average of $7.38. Anteris Technologies Global has a 1 year low of $3.30 and a 1 year high of $11.06.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on AVR shares. Barclays upgraded shares of Anteris Technologies Global to a “hold” rating in a research note on Wednesday, October 7th. Weiss Ratings restated a “sell (d-)” rating on shares of Anteris Technologies Global in a report on Wednesday, August 26th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $15.00 price target on shares of Anteris Technologies Global in a research note on Wednesday, October 14th. Three research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Anteris Technologies Global presently has a consensus rating of “Hold” and an average price target of $14.00.

Insider Buying and Selling

In other Anteris Technologies Global news, major shareholder L1 Capital Pty Ltd acquired 272,695 shares of the company’s stock in a transaction on Tuesday, October 6th. The shares were purchased at an average cost of $7.18 per share, with a total value of $1,957,950.10. Following the completion of the purchase, the insider owned 6,358,271 shares of the company’s stock, valued at approximately $45,652,385.78. This represents a 4.48% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Over the last ninety days, insiders purchased 1,554,730 shares of company stock valued at $11,694,513 and sold 810,180 shares valued at $7,270,974. Company insiders own 4.50% of the company’s stock.

Anteris Technologies Global Company Profile

Anteris Technologies Global is a medical device company focused on developing structural heart products for the treatment of heart valve disease. Its primary focus is transcatheter aortic valve replacement (TAVR), a minimally invasive procedure used to replace a diseased aortic valve without traditional open-heart surgery.

The company’s lead product is the DurAVR transcatheter heart valve, which is designed to replicate the function and hemodynamic performance of a healthy human aortic valve.